Neisseria meningitidis is a bacterium specific to man. It is frequently present in the non-pathogenic state in the throat of healthy carriers (5% to 30% of the population).

Neisseria meningitidis is a bacterium specific to man. It is frequently present in the non-pathogenic state in the throat of healthy carriers (5% to 30% of the population).

There are several strains of Neisseria meningitidis, identified by different serogroups (A, B, C, W, X, and Y). These serogroups are responsible for varying degrees of illness worldwide.

Neisseria meningitidis, a bacteria usually associated with meningitis and sepsis, has been the cause of recent cluster of sexually-transmitted infections in the USA. New research analyzing the genomes ...

Neisseria meningitidis has remained highly susceptible to antibiotics, and resistance to penicillin G and chemoprophylaxis agents is uncommon, according to data from an active population-based ...

The FDA has approved MenQuadfi as the first-ever meningococcal vaccine for babies as young as 6 weeks old. It protects against invasive meningococcal disease (IMD) caused by meningococcal bacteria ...

Neisseria meningitidis serogroups A, B, C, W, X, and Y cause outbreaks of meningococcal disease. Quadrivalent conjugate vaccines targeting the A, C, W, and Y serogroups are available. A pentavalent ...

Karlsson, J., et al. (2020) Novel hypercapsulation RNA thermosensor variants in Neisseria meningitidis and their association with invasive meningococcal disease: a genetic and phenotypic ...

Updated: Jan 27, 2025 / 03:05 PM CST MOBILE COUNTY, Ala. (WKRG) — Mobile County Health Officer Dr. Kevin Michaels has confirmed a case of bacterial infection Neisseria meningitidis in the county.

The most recent MMWR included a report about a novel, emerging strain of beta-lactamase-producing Neisseria meningitidis in the United States that is resistant to both penicillin and ciprofloxacin ...